| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2013 | EP2605650A2 Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol |
| 06/26/2013 | EP2041124B1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
| 06/26/2013 | CN1913876B Drug-containing grains and solid preparation containing the grains |
| 06/26/2013 | CN103180446A Vesicular stomatitis viruses |
| 06/26/2013 | CN103180445A Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
| 06/26/2013 | CN103180444A Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 06/26/2013 | CN103180346A Glycolipid for treatment of ischemia reperfusion injury |
| 06/26/2013 | CN103180328A Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| 06/26/2013 | CN103180327A Ring-fused 4 -aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |
| 06/26/2013 | CN103180326A 杂环化合物及其用途 Heterocyclic compounds and their use |
| 06/26/2013 | CN103180322A Pyrazole compounds as jak inhibitors |
| 06/26/2013 | CN103180321A Monohydrate of azaadamantane derivative |
| 06/26/2013 | CN103180320A 1H-pyrrolo[2,3-b]pyridine derivatives |
| 06/26/2013 | CN103180319A Inhibitors of semicarabazide - sensitive amine oxidase |
| 06/26/2013 | CN103180316A Compounds that modulate intracellular calciu |
| 06/26/2013 | CN103180315A Method of treatment for mental disorders |
| 06/26/2013 | CN103180314A Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | CN103180311A Compounds useful for inhibiting CHK1 |
| 06/26/2013 | CN103180310A Hetero-bicyclic derivatives as hcv inhibitors |
| 06/26/2013 | CN103180309A Antagonist for mutated androgen receptor |
| 06/26/2013 | CN103180299A Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 06/26/2013 | CN103180298A Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydr o-4-oxoquinoline-3-carboxamide |
| 06/26/2013 | CN103180297A Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/26/2013 | CN103180296A Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 06/26/2013 | CN103180295A 多环四环素化合物 Polycyclic tetracycline compounds |
| 06/26/2013 | CN103180293A 23-yne-vitamin D3 derivative |
| 06/26/2013 | CN103180288A Diterpenoid derivatives endowed of biological properties |
| 06/26/2013 | CN103179988A Pharmaceutical composition for transcolonic absorption |
| 06/26/2013 | CN103179974A New treatments of hepatitis c virus infection |
| 06/26/2013 | CN103179972A Use of storage stable viscous phospholipid depot to treat wounds |
| 06/26/2013 | CN103179971A Novel 6,7-disubstituted-isoquinoline derivatives and their use |
| 06/26/2013 | CN103179970A Transdermal absorption preparation |
| 06/26/2013 | CN103179969A Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies |
| 06/26/2013 | CN103179968A Aryl hydrocarbon receptor (ahr) modifiers as novel cancer therapeutics |
| 06/26/2013 | CN103179966A Vitamin e formulations of sulfamide ns3 inhibitors |
| 06/26/2013 | CN103179965A Pharmaceutical and nutraceutical compositions of abscisic acid |
| 06/26/2013 | CN103179964A Animal feed compositions of abscisic acid |
| 06/26/2013 | CN103179963A Compositions of abscisic acid for animal health |
| 06/26/2013 | CN103179962A Use of malononitrilamides in neuropathic pain |
| 06/26/2013 | CN103179961A Antifungal agents and uses thereof |
| 06/26/2013 | CN103179960A Pharmaceutical combinations for the treatment of metabolic disorders |
| 06/26/2013 | CN103179957A Pharmaceutical compositions containing dgat1 inhibitor |
| 06/26/2013 | CN103179953A Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/26/2013 | CN103179951A Phospholipid depot |
| 06/26/2013 | CN103179926A Intravaginal devices comprising anticholinergic agents, and methods of making thereof |
| 06/26/2013 | CN103173452A Aptamer capable of simultaneously identifying OdDHL ([N-(3-oxododecanoyl)-L-homoserine lactone]) and BHL (N-butanoyl-L-homoserine lactone) and application thereof |
| 06/26/2013 | CN103173334A Hippophae rhamnoides and Fagopyrum tataricum wine and its brewage method |
| 06/26/2013 | CN103172819A Biodegradable polyurethane with amino on side chain and preparation method and application thereof |
| 06/26/2013 | CN103172802A Diamino triazine hydrogen bond enhanced hydrogel based on cyclodextrin crosslinking and preparation method and application thereof |
| 06/26/2013 | CN103172693A Sterol derivative, and preparation method and application thereof |
| 06/26/2013 | CN103172692A Medical raw material as well as preparation and application thereof |
| 06/26/2013 | CN103172691A Medical raw material as well as preparation and application thereof |
| 06/26/2013 | CN103172662A Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| 06/26/2013 | CN103172658A Prodrug crystal form suitable for medicine, preparation method and pharmaceutical composition |
| 06/26/2013 | CN103172648A Tri-heterocyclic derivative, preparation method and application thereof |
| 06/26/2013 | CN103172643A Carbazole alkaloids of clausena lansium and preparation method thereof and medical composition and use thereof |
| 06/26/2013 | CN103172641A Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof |
| 06/26/2013 | CN103172633A Compound, and preparation method and application thereof |
| 06/26/2013 | CN103172631A Condensed pyrimidine derivative serving as transient receptor potential vanilla 3 (TRRV3) regulator |
| 06/26/2013 | CN103172628A (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 06/26/2013 | CN103172627A Heterocyclic benzopyrimidine or quinoline compound and applications thereof |
| 06/26/2013 | CN103172622A Active isomer of silibinin di-succinate |
| 06/26/2013 | CN103172620A Anti-viral compounds |
| 06/26/2013 | CN103172619A 4-(substituted benzyl)-1(2H)-2,3-phthalazinone derivatives, and preparation methods, medicinal compositions and uses thereof |
| 06/26/2013 | CN103172618A Ilaprazole crystal form and preparation method thereof |
| 06/26/2013 | CN103172617A Application of 1,5-2 substituent-1,2,3-triazole trifluoromethyl compound |
| 06/26/2013 | CN103172616A Novel tyrosine kinase inhibitor 1,4-disubstituted-1,2,3-triazole compound and preparation and applications thereof |
| 06/26/2013 | CN103172612A Dibenzo iodonium salts and anticancer application thereof |
| 06/26/2013 | CN103172606A Coumarin compound with anti-tumor activity |
| 06/26/2013 | CN103172605A 3-acetylcoumarin compound having PTP 1B inhibitory activity |
| 06/26/2013 | CN103172592A Salts of potassium atp channel openers and uses thereof |
| 06/26/2013 | CN103172591A Phenothiazinyl-containing Schiff base compound as well as preparation method and application thereof |
| 06/26/2013 | CN103172589A Thiazolyl-dihydroquinazolines |
| 06/26/2013 | CN103172587A Benzisothiazole-3-ketone-2-amide compound with Caspase-3 inhibiting activity |
| 06/26/2013 | CN103172579A Triazole phenyl amines compound preparation and application |
| 06/26/2013 | CN103172578A 4-ring end substituted 2-1,2,3-triazole phenylamines compound, preparation and purpose |
| 06/26/2013 | CN103172577A 4-aminoquinoline and 4-aminoquinoline compound and applications of compound |
| 06/26/2013 | CN103172576A Malic acid addition salts of Gefitinib, preparation and application |
| 06/26/2013 | CN103172573A Particulates of crth2 antagonist |
| 06/26/2013 | CN103172572A Particulates of crth2 antagonist |
| 06/26/2013 | CN103172568A Cathepsin cysteine protease inhibitors |
| 06/26/2013 | CN103172562A Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein CETP |
| 06/26/2013 | CN103172555A Indole alkaloid compound separated from rhizoma cimicifugae as well as preparation method and application thereof |
| 06/26/2013 | CN103172548A Preparation method and application of methanesulfonamide compound |
| 06/26/2013 | CN103172547A Preparation and application of sulfamide derivative |
| 06/26/2013 | CN103172543A Urea compound, preparation method and application thereof |
| 06/26/2013 | CN103172540A Phenylglycine histone deacetylase inhibitor as well as preparation method and applications thereof |
| 06/26/2013 | CN103172533A New crystal form of Aliskiren hemifumarate, and preparation method and use thereof |
| 06/26/2013 | CN103172512A Cajanin compound with similar structures, as well as preparation method and application thereof |
| 06/26/2013 | CN103172507A Ophiobollin sesterterpine compound as well as preparation method and application thereof |
| 06/26/2013 | CN103169977A Hyperbranched polymer nano-drug carrier, and preparation method thereof, anti-cancer drug nanoparticles, anti-cancer drug preparation and preparation method thereof |
| 06/26/2013 | CN103169973A Treatment of breast cancer with iodonitrobenzamides in combination with anti-tumor agents |
| 06/26/2013 | CN103169972A New application of statin compound as topical medicine for preventing and curing osteoporotic fracture |
| 06/26/2013 | CN103169971A Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| 06/26/2013 | CN103169967A Composition for improving female rate of chick embryos and preparation of composition |
| 06/26/2013 | CN103169955A Chinese herbal medicine composition for preventing and treating heat stress of chickens |
| 06/26/2013 | CN103169953A Collagen peptide-colla corii asini oral solution and preparation method thereof |
| 06/26/2013 | CN103169947A Reconstituted surfactants having improved properties |
| 06/26/2013 | CN103169944A Compound earthworm protein preparation for assistant adjustment of blood fat |
| 06/26/2013 | CN103169943A Anti-fatigue compound earthworm protein preparation |